Qentoros, Inc.
PrivateLast Round
Seed Round
Apr 24, 2026
Total Funding Raised
$120,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Qentoros, Inc. operates in Healthcare & Life Sciences and is based in Blacksburg, Virginia. Its latest recorded funding round was a Seed round in December 2025.
Qentoros, Inc. is a biotechnology company that develops orthobiologic therapeutics derived from platelets for the treatment of musculoskeletal injuries in animals and humans.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qentoros, Inc. Comparables
Compare Qentoros, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EQGen Biomedical | 89% | |
| AniCell Biotech | 86% | |
| Pegasus Orthobiologics Corporation | 84% |
For institutional investors. Book with your work email.
Qentoros, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 24, 2026 | ||||
| Seed | Dec 17, 2025 | ||||
| Accelerator | Sep 21, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qentoros, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Regional Accelerator and Mentoring Program | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
$505K raised in Seed Round.
- Dec 17, 2025
$100K round completed.
For institutional investors. Book with your work email.
Qentoros, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qentoros, Inc.'s valuation, stock price, and market status.
Is Qentoros, Inc. a public or private company?
Qentoros, Inc. is a private company.
What is the current stock price of Qentoros, Inc.?
Qentoros, Inc. is a private company, so its shares have no public market price. Caplight tracks Qentoros, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qentoros, Inc. worth (valuation)?
Valuation information for Qentoros, Inc. is not publicly available.
Can I buy Qentoros, Inc. stock?
Qentoros, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qentoros, Inc.'s last funding round?
Qentoros, Inc.'s most recent funding round was Seed Round on April 24, 2026.
Who are the main investors in Qentoros, Inc.?
Key investors in Qentoros, Inc. include Regional Accelerator and Mentoring Program.
Will Qentoros, Inc. IPO soon?
No public IPO plans have been announced for Qentoros, Inc..
How can I track Qentoros, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Qentoros, Inc.'s shares on secondary markets.